Featured Research

from universities, journals, and other organizations

Use of testosterone for 'male menopause' questionable, experts argue

Date:
June 16, 2010
Source:
BMJ-British Medical Journal
Summary:
The use of synthetic testosterone to combat symptoms of the so-called "male menopause" is questionable, given that it's not clear whether such a syndrome exists, and that the evidence of the hormone's effectiveness in these circumstances is inconclusive, says a new article.

The use of synthetic testosterone to combat symptoms of the so-called "male menopause" is questionable, given that it's not clear whether such a syndrome exists, and that the evidence of the hormone's effectiveness in these circumstances is inconclusive, says the Drug and Therapeutics Bulletin (DTB).

Unlike the menopause in women, where levels of the female hormone oestrogen plummet and production stops almost completely, in general, testosterone levels fall by only around 1 to 2% a year from the age of 40 onwards in men and production of the hormone does not stop, says DTB.

Low levels of testosterone are not an inevitable consequence of ageing, it says: around 80% of 60 year olds and half of those in their 80s still have levels within the normal range for younger men.

Low testosterone levels in older men do not necessarily produce symptoms. And symptoms sometimes attributed to low hormone levels, such as low sex drive, erection problems, diminished strength, and low mood, occur in many men with normal testosterone levels.

Overall, the evidence that an age-related reduction in testosterone levels causes specific symptoms is weak, says DTB.

These facts undermine the idea that some men develop a condition called late-onset hypogonadism, sometimes known as the "male menopause" or "andropause," it says.

The published evidence is also inconclusive on whether testosterone given to ageing men with low levels of the hormone improves symptoms, such as poor sexual function or depression.

And while there is some suggestion that it modestly increases bone density and muscle strength, whether such effects translate into worthwhile benefits, such as reduced risk of bone fractures, has not been proved.

Testosterone treatment also has several unwanted side effects, says DTB. These include a rise in prostate specific antigen (PSA), blockage of the urinary tract, development of prostate cancer and the development of breasts (gynaecomastia). And it can aggravate ischaemic heart disease, epilepsy, and sleep apnoea.

There are potential issues associated with the different ways of administering testosterone. For example, patches can irritate the skin; implants require minor surgery, which carries risks; and gels can be inadvertently transferred to other people.

Overall, DTB sees only very limited scope for treating men with testosterone who have low levels of the hormone related to age.

"Clinicians should not offer testosterone therapy without explicit discussion of the uncertainty about its risks and benefits in this population," it says.

And it concludes: "There is no place for testosterone therapy in older men without symptoms, or without clearly low testosterone concentrations on more than one occasion."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Use of testosterone for 'male menopause' questionable, experts argue." ScienceDaily. ScienceDaily, 16 June 2010. <www.sciencedaily.com/releases/2010/06/100602193318.htm>.
BMJ-British Medical Journal. (2010, June 16). Use of testosterone for 'male menopause' questionable, experts argue. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2010/06/100602193318.htm
BMJ-British Medical Journal. "Use of testosterone for 'male menopause' questionable, experts argue." ScienceDaily. www.sciencedaily.com/releases/2010/06/100602193318.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins